CAV1 and neoplasm: In 2011, Goetz et al. reported that Caveolin-1 (Cav1), an activator of Rho/ROCK signaling (Joshi et al., 2008), remodels the intratumoral microenvironment facilitating tumor invasion and correlating with increased metastatic burden.